Wednesday, May 8, 2024 5/8/2024

Diversity Supplement - Environmental surveillance of albendazole resistance markers in human infective helminths using dual amplicon metabarcoding

Award Number: R01AI155739
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY - PARENT GRANT Soil-transmitted helminth (STH) infections (intestinal worms) affect 1.5 billion individuals globally. Recent evidence from trials and modeling studies suggests that community-wide mass drug administration (cMDA) of deworming medication with sufficient coverage and adherence can eliminate STH transmission. However, in settings with ongoing environmental transmission and low coverage of networked sanitation, persistent environmental reservoirs of STH eggs result in high reinfection rates and hinder progress towards elimination. STH control programs use human stool-based methods to assess STH prevalence and intensity in endemic settings. However, individual stool sampling is expensive and logistically difficult, particularly when human infection prevalence is low. If collecting and analyzing soil from locations in communities with high human activity (e.g. home entrances, water points, schools) were established to be equally or more sensitive than human stool diagnostics, this approach may represent a less invasive and more cost-effective surveillance tool for MDA program monitoring and evaluation. This study will leverage a multi-country cluster-randomized controlled trial delivering three-years of biannual cMDA in Benin and India (DeWorm3). The trial will collect and analyze human stool samples 6 months and 24 months (n=120,000 in total) after the final round of cMDA, which will yield highly accurate human STH infection prevalence estimates in the study areas. Through extensive laboratory studies and field testing in India and Benin, our team has developed a sensitive and specific molecular method for detecting STH environmental DNA (eDNA) in large volumes of soil. We will nest soil sampling within the trial at the same time points as human stool collection with the specific aims to: 1) Quantify the effect of a biannual cMDA intervention on the soil STH reservoir; 2) Determine whether soil STH eDNA levels can predict community-level human STH infection prevalence; and 3) Develop the optimal soil sampling strategy and compare costs to human stool-based surveillance. Pairing soil STH eDNA assessments with human infection prevalence data already being collected by the DeWorm3 trial is a unique and time sensitive opportunity to validate and test the utility of environmental STH surveillance. Our findings will also contribute to understanding the conditions under which MDA program integration with improved sanitation interventions is needed for achieving sustained reductions in STH infection prevalence.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $49,203 )
2024	2024	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Allergy and Infectious Diseases Research	000	3	2/27/2024	SUPPLEMENT FOR EXPANSION	$49,203
														Subtotal = $49,203

Issue Date FY: 2023 ( Subtotal = $662,242 )
2023	2023	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Allergy and Infectious Diseases Research	000	3	7/13/2023	NON-COMPETING CONTINUATION	$662,242
														Subtotal = $662,242

Issue Date FY: 2022 ( Subtotal = $747,708 )
2022	2022	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Allergy and Infectious Diseases Research	001	2	6/30/2022	NON-COMPETING CONTINUATION	$670,040
2022	2022	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 201	BERKELEY	CA	94710	ALAMEDA	USA	Allergy and Infectious Diseases Research	000	1	3/14/2022	SUPPLEMENT FOR EXPANSION	$77,668
														Subtotal = $747,708

Issue Date FY: 2021 ( Subtotal = $627,723 )
2021	2021	REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE	1608 4TH ST STE 220	BERKELEY	CA	94710	ALAMEDA	USA	Allergy and Infectious Diseases Research	000	1	7/13/2021	NEW	$627,723
														Subtotal = $627,723

Grand Total All Awards = $2,086,876

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Diversity Supplement - Environmental surveillance of albendazole resistance markers in human infective helminths using dual amplicon metabarcoding

Award Number: R01AI155739

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer